表紙
市場調查報告書
商品編碼
974907

抗凝血酵素的全球市場 (2017-2025年):產業分析、市場趨勢、市場佔有率、成長預測 (各用途、原料、劑型、地區)

Antithrombin Market (Application - Therapeutics, Research, and Diagnostics; Source - Human, and Goat Milk; Dosage Form - Lyophilized and Liquid) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

出版日期: | 出版商: Transparency Market Research | 英文 175 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球抗凝血酵素的市場調查,市場定義和概要,市場成長的各種影響因素分析,開發平台分析,主要產品、品牌分析,市場規模的變化、預測,用途、原料、劑型、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊彙整。

第1章 序文

第2章 假設、調查手法

第3章 摘要整理

第4章 市場概要

  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 市場分析、預測

第5章 重要考察

  • 開發平台分析
  • 全球主要產品、品牌分析
  • 醫療保健產業概要

第6章 市場分析、預測:各用途

  • 主要調查結果、主要的展開
  • 市場變化、預測
    • 治療
    • 研究
    • 診斷
  • 市場魅力

第7章 市場分析、預測:各原料

  • 主要調查結果、主要的展開
  • 市場變化、預測
    • 山羊奶
    • 其他(牛等)
  • 市場魅力

第8章 市場分析、預測:各劑型

  • 主要調查結果、主要的展開
  • 市場變化、預測
    • 冷凍乾燥
    • 液體
  • 市場魅力

第9章 市場分析、預測:各地區

  • 主要調查結果
  • 市場變化、預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • 市場魅力

第10章 北美市場分析、預測:各主要國家

第11章 歐洲市場分析、預測:各主要國家

第12章 亞太地區市場分析、預測:各主要國家

第13章 南美市場分析、預測:各主要國家

第14章 中東、非洲市場分析、預測:各主要國家

第15章 競爭情形

  • 進入經營者、競爭矩陣
  • 市場佔有率分析、企業排行榜
  • 企業簡介
    • rEVO Biologics, Inc.
    • Grifols
    • Shire plc.
    • CSL Limited
    • Kedrion SpA
    • Octapharma AG
    • Dem ilac Inc.
    • Lee Bisolutions
    • Diapharma
    • Scripps Laboratories, Inc.
目錄
Product Code: TMRGL4500

Global Antithrombin Treatment Market - Scope of Report

TMR's report on the global antithrombin treatment market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global antithrombin treatment market for the period 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global antithrombin treatment market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global antithrombin treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global antithrombin treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global antithrombin treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global antithrombin treatment market.

The report delves into the competitive landscape of the global antithrombin treatment market. Key players operating in the global antithrombin treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global antithrombin treatment market that have been profiled in this report.

Key Questions Answered in Global Antithrombin Treatment Market Report

What is the scope of growth for product companies in the global antithrombin treatment market?

What will be the Y-o-Y growth of the global antithrombin treatment market between 2019 and 2027?

What is the influence of changing trends in technologies on the global antithrombin treatment market?

Will North America continue to be the most profitable market for antithrombin treatment providers?

Which factors are anticipated to hamper the growth of the global antithrombin treatment market during the forecast period?

Which are the leading companies in the global antithrombin treatment market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global antithrombin treatment market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary research sources referred to by analysts during the production of the global antithrombin treatment market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the antithrombin treatment market as primary methods.

These primary research respondents have provided exclusive information during interviews, which serves as a validation from the antithrombin treatment market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global antithrombin treatment market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global antithrombin treatment more reliably and accurately.

Regional Segmentation of Antithrombin Treatment Market

North America

U.S.

Canada

Europe

Germany

U.K.

France

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

Australia & New Zealand

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Antithrombin Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Application Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Antithrombin Treatment Market Analysis and Forecasts, 2017-2027

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis Globally: Snapshot
  • 5.3. Healthcare Industry Overview

6. Global Antithrombin Treatment Market Analysis and Forecasts, By Application

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Antithrombin Treatment Market Value Forecast By Application, 2017-2027
    • 6.3.1. Therapeutic
    • 6.3.2. Research
    • 6.3.3. Diagnostics
  • 6.4. Global Antithrombin Treatment Market Attractiveness By Application

7. Global Antithrombin Treatment Market Analysis and Forecasts, By Source

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Antithrombin Treatment Market Value Forecast By Source, 2017-2027
    • 7.3.1. Human
    • 7.3.2. Goat Milk
    • 7.3.3. Others (Bovine, etc.)
  • 7.4. Global Antithrombin Treatment Market Attractiveness By Source

8. Global Antithrombin Treatment Analysis and Forecasts, By Dosage Form

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Global Antithrombin Treatment Market Value Forecast By Dosage Form, 2017-2027
    • 8.3.1. Lyophilized
    • 8.3.2. Liquid
  • 8.4. Global Antithrombin Treatment Market Attractiveness By Dosage Form

9. Global Antithrombin Treatment Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Global Antithrombin Treatment Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Global Antithrombin Treatment Market Attractiveness By Country/Region

10. North America Antithrombin Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. North America Antithrombin Treatment Market Value Forecast By Application, 2017-2027
    • 10.2.1. Therapeutic
    • 10.2.2. Research
    • 10.2.3. Diagnostics
  • 10.3. North America Antithrombin Treatment Market Value Forecast By Source, 2017-2027
    • 10.3.1. Human
    • 10.3.2. Goat Milk
    • 10.3.3. Others (Bovine, etc.)
  • 10.4. North America Antithrombin Treatment Market Value Forecast By Dosage Form, 2017-2027
    • 10.4.1. Lyophilized
    • 10.4.2. Liquid
  • 10.5. North America Antithrombin Treatment Market Value Forecast By Country, 2017-2027
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Antithrombin Treatment Market Attractiveness Analysis
    • 10.6.1. By Application
    • 10.6.2. By Source
    • 10.6.3. By Dosage Form
    • 10.6.4. By Country

11. Europe Antithrombin Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Europe Antithrombin Treatment Market Value Forecast By Application, 2017-2027
    • 11.2.1. Therapeutic
    • 11.2.2. Research
    • 11.2.3. Diagnostics
  • 11.3. Europe Antithrombin Treatment Market Value Forecast By Source, 2017-2027
    • 11.3.1. Human
    • 11.3.2. Goat Milk
    • 11.3.3. Others (Bovine, etc.)
  • 11.4. Europe Antithrombin Treatment Market Value Forecast By Dosage Form, 2017-2027
    • 11.4.1. Lyophilized
    • 11.4.2. Liquid
  • 11.5. Europe Antithrombin Treatment Market Value Forecast By Country/Sub-region, 2017-2027
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Europe Antithrombin Treatment Market Attractiveness Analysis
    • 11.6.1. By Application
    • 11.6.2. By Source
    • 11.6.3. By Dosage Form
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Antithrombin Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Asia Pacific Antithrombin Treatment Market Value Forecast By Application, 2017-2027
    • 12.2.1. Therapeutic
    • 12.2.2. Research
    • 12.2.3. Diagnostics
  • 12.3. Asia Pacific Antithrombin Treatment Market Value Forecast By Source, 2017-2027
    • 12.3.1. Human
    • 12.3.2. Goat Milk
    • 12.3.3. Others (Bovine, etc.)
  • 12.4. Asia Pacific Antithrombin Treatment Market Value Forecast By Dosage Form, 2017-2027
    • 12.4.1. Lyophilized
    • 12.4.2. Liquid
  • 12.5. Asia Pacific Antithrombin Treatment Market Value Forecast By Country/Sub-region, 2017-2027
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Asia Pacific Antithrombin Treatment Market Attractiveness Analysis
    • 12.6.1. By Application
    • 12.6.2. By Source
    • 12.6.3. By Dosage Form
    • 12.6.4. By Country/Sub-region

13. Latin America Antithrombin Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Latin America Antithrombin Treatment Market Value Forecast By Application, 2017-2027
    • 13.2.1. Therapeutic
    • 13.2.2. Research
    • 13.2.3. Diagnostics
  • 13.3. Latin America Antithrombin Treatment Market Value Forecast By Source, 2017-2027
    • 13.3.1. Human
    • 13.3.2. Goat Milk
    • 13.3.3. Others (Bovine, etc.)
  • 13.4. Latin America Antithrombin Treatment Market Value Forecast By Dosage Form, 2017-2027
    • 13.4.1. Lyophilized
    • 13.4.2. Liquid
  • 13.5. Latin America Antithrombin Treatment Market Value Forecast By Country/Sub-region, 2017-2027
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Latin America Antithrombin Treatment Market Attractiveness Analysis
    • 13.6.1. By Application
    • 13.6.2. By Source
    • 13.6.3. By Dosage Form
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Antithrombin Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Middle East & Africa Antithrombin Treatment Market Value Forecast By Application, 2017-2027
    • 14.2.1. Therapeutic
    • 14.2.2. Research
    • 14.2.3. Diagnostics
  • 14.3. Middle East & Africa Antithrombin Treatment Market Value Forecast By Source, 2017-2027
    • 14.3.1. Human
    • 14.3.2. Goat Milk
    • 14.3.3. Others (Bovine, etc.)
  • 14.4. Middle East & Africa Antithrombin Treatment Market Value Forecast By Dosage Form, 2017-2027
    • 14.4.1. Lyophilized
    • 14.4.2. Liquid
  • 14.5. Middle East & Africa Antithrombin Treatment Market Value Forecast By Country/Sub-region, 2017-2027
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Antithrombin Treatment Market Attractiveness Analysis
    • 14.6.1. By Application
    • 14.6.2. By Source
    • 14.6.3. By Dosage Form
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis/Ranking By Company (2018)
  • 15.3. Company Profiles
    • 15.3.1. rEVO Biologics, Inc.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Growth Strategies
      • 15.3.1.3. SWOT Analysis.
    • 15.3.2. Grifols
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Growth Strategies
      • 15.3.2.3. SWOT Analysis.
    • 15.3.3. Shire plc.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Growth Strategies
      • 15.3.3.3. SWOT Analysis.
    • 15.3.4. CSL Limited
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Growth Strategies
      • 15.3.4.3. SWOT Analysis.
    • 15.3.5. Kedrion S.p.A
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Growth Strategies
      • 15.3.5.3. SWOT Analysis.
    • 15.3.6. Octapharma AG
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Growth Strategies
      • 15.3.6.3. SWOT Analysis.
    • 15.3.7. Dem ilac Inc.
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Growth Strategies
      • 15.3.7.3. SWOT Analysis.
    • 15.3.8. Lee Bisolutions
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Growth Strategies
      • 15.3.8.3. SWOT Analysis.
    • 15.3.9. Diapharma
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Growth Strategies
      • 15.3.9.3. SWOT Analysis.
    • 15.3.10. Scripps Laboratories, Inc.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Growth Strategies
      • 15.3.10.3. SWOT Analysis.

List of Table

  • Table 01: Global Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017-2027
  • Table 02: Global Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017-2027
  • Table 03: Global Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2027
  • Table 04: Global Antithrombin Market Size (US$ Mn) Forecast, by Region, 2017-2027
  • Table 05: North America Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017-2027
  • Table 06: North America Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017-2027
  • Table 07: North America Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017-2027
  • Table 08: North America Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2027
  • Table 09: Europe Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017-2027
  • Table 10: Europe Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017-2027
  • Table 11: Europe Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017-2027
  • Table 12: Europe Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2027
  • Table 13: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017-2027
  • Table 14: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017-2027
  • Table 15: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017-2027
  • Table 16: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2027
  • Table 17: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017-2027
  • Table 18: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017-2027
  • Table 19: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017-2027
  • Table 20: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2027
  • Table 21: Middle East & Africa Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017-2027
  • Table 22: Middle East & Africa Size (US$ Mn) Forecast, by Source, 2017-2027
  • Table 23: Middle East & Africa Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2027

List of Figure

  • Figure 01: Global Antithrombin Market Size (US$ Mn) Forecast, 2017-2027
  • Figure 02: Market Value Share, by Region 2018
  • Figure 03: Market Value Share, by Application 2018
  • Figure 04: Market Value Share, by Source 2018
  • Figure 05: Market Value Share, by Dosage Form 2018
  • Figure 06: Global Antithrombin Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 07: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2017-2027
  • Figure 08: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Research, 2017-2027
  • Figure 09: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2017-2027
  • Figure 10: Global Antithrombin Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 11: Global Antithrombin Market Value Share Analysis, by Source, 2018 and 2027
  • Figure 12: Global Antithrombin Market Revenue (US$ Mn), by Human Source, 2017-2027
  • Figure 13: Global Antithrombin Market Revenue (US$ Mn), by Goat Milk Source, 2017-2027
  • Figure 14: Global Antithrombin Market Revenue (US$ Mn), by Others, 2017-2027
  • Figure 15: Global Antithrombin Market Attractiveness Analysis, by Source, 2019-2027
  • Figure 16: Global Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027
  • Figure 17: Global Antithrombin Market Revenue (US$ Mn), by Lyophilized Dosage Form, 2017-2027
  • Figure 18: Global Antithrombin Market Revenue (US$ Mn), by Liquid Dosage Form, 2017-2027
  • Figure 19: Global Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019-2027
  • Figure 20: Global Antithrombin Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 21: Global Antithrombin Market Attractiveness Analysis, by Region, 2017-2027
  • Figure 22: North America Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 23: North America Antithrombin Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 24: North America Antithrombin Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 25: North America Antithrombin Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 26: North America Antithrombin Market Value Share Analysis, by Source, 2018 and 2027
  • Figure 27: North America Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027
  • Figure 28: North America Antithrombin Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 29: North America Antithrombin Market Attractiveness Analysis, by Source, 2019-2027
  • Figure 30:North America Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019-2027
  • Figure 31: Europe Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 32: Europe Antithrombin Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 33: Europe Antithrombin Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 34: Europe Antithrombin Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 35: Europe Antithrombin Market Value Share Analysis, by Source, 2018 and 2027
  • Figure 36: Europe Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027
  • Figure 37: Europe Antithrombin Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 38: Europe Antithrombin Market Attractiveness Analysis, by Source, 2019-2027
  • Figure 39: Europe Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019-2027
  • Figure 40: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2027
  • Figure 41: Asia Pacific Antithrombin Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 42: Asia Pacific Antithrombin Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 43: Asia Pacific Antithrombin Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 44: Asia Pacific Antithrombin Market Value Share Analysis, by Source, 2018 and 2027
  • Figure 45: Asia Pacific Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027
  • Figure 46: Asia Pacific Antithrombin Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 47: Asia Pacific Antithrombin Market Attractiveness Analysis, by Source, 2019-2027
  • Figure 48:Asia Pacific Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019-2027
  • Figure 49: Latin America Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 50: Latin America Antithrombin Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 51: Latin America Antithrombin Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 52: Latin America Antithrombin Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 53: Latin America Antithrombin Market Value Share Analysis, by Source, 2018 and 2027
  • Figure 54: Latin America Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027
  • Figure 55: Latin America Antithrombin Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 56: Latin America Antithrombin Market Attractiveness Analysis, by Source, 2019-2027
  • Figure 57: Latin America Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019-2027
  • Figure 58: Middle East & Africa Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 59: Middle East & Africa Antithrombin Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 60: Middle East & Africa Antithrombin Market Value Share Analysis, by Source, 2018 and 2027
  • Figure 61: Rest of the World Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027
  • Figure 62: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Application, 2019-2027
  • Figure 63: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Source, 2019-2027
  • Figure 64: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019-2027
  • Figure 65: Heat Map Analysis By Company 2018
  • Figure 66: Revenue for the LFB Group (US$ Mn) and Y-o-Y Growth (%), 2014-2018
  • Figure 67: Breakdown of Net Sales, by Business Segment, 2018
  • Figure 68: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2018
  • Figure 69: Breakdown of Net Sales, by Business Segment, 2018
  • Figure 70: Revenue (US$ Bn) and Y-o-Y Growth (%), 2014-2018
  • Figure 71: Breakdown of Net Sales, by Region, 2018
  • Figure 72: CSL Limited Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2018
  • Figure 73: Breakdown of Net Sales by Business segments, 2018
  • Figure 74: Company Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2018
  • Figure 75: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2018